Yohann Loriot
MD, PhD
Professor of Medicine, GU Oncology
👥Biography 个人简介
Yohann Loriot is a leading European investigator in advanced urothelial cancer therapeutics. He has been instrumental in the development of FGFR inhibitors and ADC-based therapies for bladder cancer. His clinical trial leadership and translational research on DNA damage repair deficiency have expanded treatment options for molecularly defined patient populations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Yohann Loriot 的研究动态
Follow Yohann Loriot's research updates
留下邮箱，当我们发布与 Yohann Loriot（Gustave Roussy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment